共 233 条
- [11] Wilkinson SP(1998)Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors Am J Gastroenterol 93 763-767
- [12] Foster DN(1998)Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects Gastroenterology 115 1335-1339
- [13] Mountford RA(1995)Comparison of acid-inhibitory effect of omeprazole in before-breakfast dosing and after-breakfast dosing [in Japanese] Jpn Pharmacol Ther 23 879-885
- [14] Temperley JM(1996)Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls Am J Gastroenterol 91 1532-1538
- [15] Harvey RF(1998)Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily Aliment Pharmacol Ther 12 1235-1240
- [16] Thompson DG(2003)The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity Aliment Pharmacol Ther 17 1553-1558
- [17] Davis M(1990)Loss of acid suppression during dosing with H2-receptor antagonists Aliment Pharmacol Ther 4 15-27
- [18] Forgacs IC(1990)Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine Aliment Pharmacol Ther 4 29-45
- [19] Bassett KS(1990)Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin Aliment Pharmacol Ther 4 47-63
- [20] Richardson PDI(1990)The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin Aliment Pharmacol Ther 4 65-74